These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
547 related items for PubMed ID: 20587123
1. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P. Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123 [Abstract] [Full Text] [Related]
2. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study. Heijstek MW, van Gageldonk PG, Berbers GA, Wulffraat NM. Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491 [Abstract] [Full Text] [Related]
3. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China. Li YT, Luo XQ, Zhong XB, Cai LM, Zhu LP, Chen XQ, Wang KC, Chen ZG. Vaccine; 2020 May 13; 38(23):3960-3967. PubMed ID: 32321685 [Abstract] [Full Text] [Related]
4. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K, Nicoara C, Germann D, Matter L. Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837 [Abstract] [Full Text] [Related]
5. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Sultana R, Rahman MM, Hassan Z, Hassan MS. Scand J Immunol; 2006 Dec 25; 64(6):684-9. PubMed ID: 17083626 [Abstract] [Full Text] [Related]
9. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96]. Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C. Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798 [Abstract] [Full Text] [Related]
10. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt? Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA. East Mediterr Health J; 2009 Jun 10; 15(1):85-93. PubMed ID: 19469430 [Abstract] [Full Text] [Related]
13. Serosurvey of measles, mumps and rubella antibodies in Saudi children. Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA. Saudi Med J; 2005 Oct 10; 26(10):1551-4. PubMed ID: 16228054 [Abstract] [Full Text] [Related]
14. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid]. Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A. An Esp Pediatr; 1999 May 10; 50(5):459-62. PubMed ID: 10394183 [Abstract] [Full Text] [Related]
15. Measles, mumps and rubella: control by vaccination. van Druten JA, de Boo T, Plantinga AD. Dev Biol Stand; 1986 May 10; 65():53-63. PubMed ID: 3556777 [Abstract] [Full Text] [Related]
16. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox]. Buxbaum S, Doerr HW, Allwinn R. Dtsch Med Wochenschr; 2001 Nov 16; 126(46):1289-93. PubMed ID: 11709730 [Abstract] [Full Text] [Related]
17. Rubella seroprevalence among young women taipei county after routine measles, mumps and rubella immunization program. Wang IJ, Hwang KC, Tsai YH, Wu YN, Chao SJ, Chen TE, Huang LM. Acta Paediatr Taiwan; 2006 Nov 16; 47(1):14-7. PubMed ID: 17016964 [Abstract] [Full Text] [Related]